1Slamon DJ,Clark CM,Wong SG,et al.Human breast cancer correlation of relapse and survival with amplification of the HER-2/neu oncegene.Science,1987,235:177-181.
2Heintz NH,Leslie KO,Rogers LA,et at.Amplification of the C-rebB-2 oncogene in prognosis of breast adenocarcinoma.Arch Pathol Lab Med,1990,144:160-163.
3Jeffrey S Ross,Jonathan A.Fletcher The HER-2/neu Oncogene in breast cancer,prognostic factor,predictive factor,and target for therapy.Stem Cel,1998,16:413-428.
4Numes RA,Harris LN.The HER-2 cxtraccllular domain as a prognestic and predictive factor in breast cancer.Clin Breast Cancer,2002,3:125-135.
7Horignchi J,Koibuchi Y,Lijima K,et al.Co-experased type of ER and HER-2 predictive in determining resistance to antiestrogen therapy in patients with ER-positive and HER-2-positive breast cancer.Oncol Bep,2005,14:1109-1116.
8Buter J A,Bretsky s,Menende-Botet C,et al.Estrogen reecpertor prote in of breast cancer as a predictor of recurrence.Cancer,1985.55:1178-1181.
9Berry DA,Muss HB,Thor AD,et al.HER-2/neu and p53 eXpression versus tamoxifen resistance in estrogen receptor-positive,node-positive breast cancer.J Clin Oncel,2000,18:3471-3479.
